Displaying 1 - 3 of 3
Author:Pardo, Gabriel Hauser, Stephen Bar-Or, Amit Gold, Ralf Montalban, Xavier Cohen, Jeffrey Robertson, Derrick Hersh, Carrie Naismith, Robert Deiva, Kumaran Bhatt, Alit Fu, Haoyi Boer, Ibolya Meuth, Sven Cross, Anne Gärtner, Jutta Kappos, Ludwig
Session Name:S31: Multiple Sclerosis: Therapeutics and Clinical Decision Making
Topic:Multiple Sclerosis
Program Number:S31.003
Author Institution:Oklahoma Medical Research Foundation, Oklahoma, USA, Oklahoma City, OK UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California, USA, San Francisco, CA Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA Department of Neurology, Katholisches Klinikum Bochum, Ruhr-Universität Bochum, Bochum, Germany, Bochum, Germany Department of Neurology Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d’Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA, Cleveland, OH Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, Florida, USA, Tampa, FL Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, United States, Las Vegas, NV Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri, USA, Saint Louis, MO Department of Pediatric Neurology, University Hospitals Paris Saclay, Hôpital Bicêtre, National Reference Center for Rare Inflammatory Brain and Spinal Diseases, Le Kremlin Bicêtre, France, Le Kremlin Bicêtre, France Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Novartis Pharma AG, Basel, Switzerland, Basel, Switzerland Department of Neurology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany, Duesseldorf, Germany Department of Neurology, Section of Neuroimmunology, Washington University School of Medicine, Saint Louis, Missouri, USA, Clayton, MO Department of Paediatrics and Adolescent Medicine, Division of Paediatric Neurology, University Medical Centre Göttingen, Georg August University Göttingen, Göttingen, Germany, Göttingen, Germany Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Head, Organs, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Filippi, Massimo Riolo, Jon Cohen, Jeffrey Hartung, Hans-Peter Montalban, Xavier Meuth, Sven Freeman, Leorah Chitnis, Tanuja Granziera, Cristina Deboer, Erik Cheng, Chun-Yen Reardon, Jennifer Pachai, Chahin Sheffield, James Cree, Bruce Kappos, Ludwig
Session Name:P6: Multiple Sclerosis: Clinical Assessments Including Digital Tools and Outcome Measures 2
Topic:Multiple Sclerosis
Program Number:P6.014
Author Institution:Neuroimaging Research Unit, Division of Neuroscience, Neurology Unit, Neurorehabilitation Unit, and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, and Vita-Salute San Raffaele University, Milan, Italy, Milan, Italy Bristol Myers Squibb, Princeton, New Jersey, USA, Princeton, NJ Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, USA, Cleveland, OH Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany Brain and Mind Centre, University of Sydney, Sydney, Australia Department of Neurology, Medical University of Vienna, Vienna, Austria and Palacký University Olomouc, Olomouc, Czech Republic, Dusseldorf, Germany Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany, Duesseldorf, Germany Dell Medical School, The University of Texas at Austin, Austin, Texas, USA, Austin, TX Brigham and Women’s Hospital, and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA, Boston, MA Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland Department of Neurology, University Hospital Basel, Switzerland Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland Bristol Myers Squibb, Princeton, New Jersey, USA, New York, NY Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, USA , San Francisco, CA
Author:Wiendl, Heinz Hauser, Stephen Nicholas, Jacqueline De Seze, Jerome Meuth, Sven Giacomini, Paul Robertson, Derrick Wray, Sibyl Bhatt, Alit Hu, Xixi Fu, Haoyi Jehl, Valentine Sullivan, Roseanne Boer, Ibolya Cohen, Jeffrey Kappos, Ludwig
Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2
Topic:Multiple Sclerosis
Program Number:P9.010
Author Institution:University of Münster, Münster, Germany, Muenster, Germany UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, United States, San Francisco, CA OhioHealth Multiple Sclerosis Center, Columbus, OH, USA, Columbus, OH University Hospital of Strasbourg, Strasbourg, France, Strasbourg, France Department of Neurology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany, Duesseldorf, Germany Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada Multiple Sclerosis Division, Department of Neurology, University of South Florida, Tampa, FL, USA, Tampa, FL Hope Neurology MS Center, Knoxville, TN, USA, Knoxville, TN Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, Morristown, NJ Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, East Hanover, NJ Novartis Pharma A.G. Basel, Switzerland, Basel, Switzerland Department of Neurology, Mellen MS Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA, Cleveland, OH Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB) and MS Center, Departments of Headorgans, Spine and Neuromedicine, Clinical Research, Biomedicine and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Displaying 1 - 3 of 3